More articles from Commentary

You have access
A Risk-Based Auditing Process for Pharmaceutical Manufacturers
Susan Vargo, Bob Dana, Vijaya Rangavajhula and Stephan Rönninger

PDA Journal of Pharmaceutical Science and Technology March 2014, 68 (2) 104-112; DOI: https://doi.org/10.5731/pdajpst.2014.00954
You have access
Risk-based Process Development of Biosimilars as Part of the Quality by Design Paradigm
Dénes Zalai, Christian Dietzsch and Christoph Herwig

PDA Journal of Pharmaceutical Science and Technology November 2013, 67 (6) 569-580; DOI: https://doi.org/10.5731/pdajpst.2013.00943
You have access
Enabling ICH Q10 Implementation—Part 1. Striving for Excellence by Embracing ICH Q8 and ICH Q9
Nuala Calnan, Kevin O'Donnell and Anne Greene

PDA Journal of Pharmaceutical Science and Technology November 2013, 67 (6) 581-600; DOI: https://doi.org/10.5731/pdajpst.2013.00940
You have access
The Application of Quality Risk Management to the Bacterial Endotoxins Test: Use of Hazard Analysis and Critical Control Points
Carducci Annalaura, Davini Giulia and Ceccanti Stefano

PDA Journal of Pharmaceutical Science and Technology September 2013, 67 (5) 553-567; DOI: https://doi.org/10.5731/pdajpst.2013.00938
You have access
Perspectives on the PQRI Extractables and Leachables “Safety Thresholds and Best Practices” Recommendations for Inhalation Drug Products
Daniel L. Norwood, Lee M. Nagao and Cheryl L. M. Stults

PDA Journal of Pharmaceutical Science and Technology September 2013, 67 (5) 413-429; DOI: https://doi.org/10.5731/pdajpst.2013.00934
You have access
Can Quality Solve the Equation? ⇓ Pricing + ⇑ Health Authority Expectations + ⇑ Supply Chain Complexity + ⇑ Counterfeiting = Quality Drugs to Patients + an Engaged Workforce
Jennifer Magnani and Anders Vinther

PDA Journal of Pharmaceutical Science and Technology November 2012, 66 (6) 518-525; DOI: https://doi.org/10.5731/pdajpst.2012.00893
You have access
The Reliability-Quality Relationship for Quality Systems and Quality Risk Management
H. Gregg Claycamp, Faiad Rahaman and Jason M. Urban

PDA Journal of Pharmaceutical Science and Technology November 2012, 66 (6) 512-517; DOI: https://doi.org/10.5731/pdajpst.2012.00888
You have access
Considerations on Auditing and GxP Requirements along the Product Lifecycle
Stephan Rönninger, Siegfried Schmitt, Vijaya Rangavajhula, Emily Hough and Jim Lyda

PDA Journal of Pharmaceutical Science and Technology September 2012, 66 (5) 396-402; DOI: https://doi.org/10.5731/pdajpst.2012.00881
You have access
Reliable Drug Quality: An Unresolved Problem
Janet Woodcock

PDA Journal of Pharmaceutical Science and Technology May 2012, 66 (3) 270-272; DOI: https://doi.org/10.5731/pdajpst.2012.00868
You have access
A General Strategy for the Chemical Aspects of the Safety Assessment of Extractables and Leachables in Pharmaceutical Drug Products: The Chemical Assessment Triad
Dennis Jenke

PDA Journal of Pharmaceutical Science and Technology March 2012, 66 (2) 168-183; DOI: https://doi.org/10.5731/pdajpst.2012.00855

Main menu

User menu

Search

More articles from Commentary

Pages

Readers

Author/Reviewer Information

Parenteral Drug Association, Inc.